Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 25, 2018 - Issue 2
181
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Primary adrenal insufficiency due to hereditary apolipoprotein AI amyloidosis: endocrine involvement beyond hypogonadism

ORCID Icon, , ORCID Icon, ORCID Icon, , , , , , ORCID Icon & ORCID Icon show all
Pages 75-78 | Received 02 Nov 2017, Accepted 05 Feb 2018, Published online: 15 Feb 2018

References

  • Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:364–389.
  • Ozdemir D, Dagdelen S, Erbas T. Endocrine involvement in systemic amyloidosis. Endocr Pract. 2010;16:1056–1063.
  • Kyle RA. Amyloidosis: a convoluted story. Br J Haematol. 2001;114:529–538.
  • Eriksson M, Schönland S, Yumlu S, et al. Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens. J Mol Diagnostics. 2009;11:257–262.
  • Joy T, Wang J, Hahn A, et al. APOA1 related amyloidosis: a case report and literature review. Clin Biochem. 2003;36:641–645.
  • Scalvini T, Martini PR, Obici L, et al. Infertility and hypergonadotropic hypogonadism as first evidence of hereditary apolipoprotein A-I amyloidosis. J Urol. 2007;178:344–348.
  • Arciello A, Piccoli R, Monti DM. Apolipoprotein A-I: the dual face of a protein. FEBS Lett. 2016;590:4171–4179.
  • Obici L, Franceschini G, Calabresi L, et al. Structure, function and amyloidogenic propensity of apolipoprotein A-I. Amyloid. 2006;13:1–15.
  • Rowczenio D, Dogan A, Theis JD, et al. Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I. Am J Pathol. 2011;179:1978–1987.
  • Traynor CA, Tighe D, O’Brien FJ, et al. Clinical and pathologic characteristics of hereditary apolipoprotein A-I amyloidosis in Ireland. Nephrology. 2013;18:549–554.
  • Booth DR, Tan SY, Booth SE, et al. Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein al gene. J Clin Invest. 1996;97:2714–2721.
  • Caballería J, Bruguera M, Sole M, et al. Hepatic familial amyloidosis caused by a new mutation in the apolipoprotein AI gene: clinical and pathological features. Am J Gastroenterol. 2001;96:1872–1876.
  • Gregorini G, Izzi C, Obici L, et al. Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis. J Am Soc Nephrol. 2005;16:3680–3686.
  • Obici L, Palladini G, Giorgetti S, et al. Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families. Gastroenterology. 2004;126:1416–1422.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.